Dubai Culture Launches ‘Creative Dubai – Navigating Tomorrow’s Creative Landscape’ Report
Dubai Culture and Arts Authority (Dubai Culture) has launched the ‘Creative Dubai: Navigating Tomorrow’s Creative Landscape’ report developed in collaboration with DinarStandard, a privately owned growth strategy research and advisory firm empowering organisations for responsible global impact. The report highlights Dubai’s achievements in the cultural and creative industries, the key factors contributing to the city’s cultural vision, and significant data tracking the sector’s transformation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250112169940/en/
Key Highlights of Creative Economy Figures and FDI in Dubai’s Cultural and Creative Industries (Graphic: AETOSWire)
The report provides a comprehensive overview of the creative sector, which serves as a significant global economic force, representing 6.1% of the global economy with a total value of US$4.3 trillion. The report also shows that the UAE has the largest creative sector in the MENA region in 2021, with a size of US$13.7 billion.
According to the Dubai Framework for Cultural Statistics, Dubai’s cultural and creative industries generated AED 21.96 billion in added value in 2022, contributing 4.6% to the emirate’s GDP. The report indicates that 47,544 companies operate in Dubai’s creative sectors, providing jobs for 175,727 employees, reflecting the size and impact of Dubai’s creative economy. In addition, Dubai successfully attracted 898 foreign direct investment (FDI) projects in the cultural and creative industries in 2023, increasing total capital inflows for FDI projects to AED 11.8 billion. Additionally, the report reveals that Dubai is home to more than 40% of start-ups that have secured over USD 1 million in funding in the MENA region, with 306 start-ups based in the emirate.
The report highlights how Dubai’s robust infrastructure, business enabling and cultural environment have significantly contributed to its global leadership. It also provides a comprehensive set of recommendations to foster the growth of Dubai’s creative sector, including key opportunity hotspots for investors, showcasing the most dynamic and rapidly expanding cultural and creative domains. A strong emphasis is placed on the need for affordable technological solutions tailored to SMEs, adopting a hybrid business model that seamlessly integrates physical and digital operations, and the importance of developing integrated curricula that connect the creative industry with educational institutions, ensuring a sustainable talent pipeline and industry growth.
To view the full report, visit https://www.dubaiculture.gov.ae/.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250112169940/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bynder Showcases Its New and Expanded AI Capabilities at NRF to Help Retailers Drive Personalized Content Experiences13.1.2025 12:24:00 CET | Press release
Bynder, a global leader in AI-powered enterprise DAM, is showcasing its latest AI innovations at the NRF retail show in New York. These new innovations build on the company’s already extensive set of AI capabilities, to help power global brands to drive personalized content experiences. During the show, Bynder revealed its Natural Language Search functionality which will help DAM users find images quickly by simply describing them in all major languages. Bynder already has more than 500 customers leveraging its existing AI Search capabilities such as similarity search, text in image and facial recognition. In addition to this, Bynder launched its next generation Duplicate Image Finder which helps organize and maintain a brand’s DAM by detecting and removing duplicate images at the touch of a button. This enhanced feature is now AI assisted to detect exact duplicate images with greater accuracy and allow administrators to easily delete them from the DAM. For retailers that include video
Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs13.1.2025 12:15:00 CET | Press release
This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that address the full range of product requirements. In response to the growing demand for peptide drugs, Cytovance Biologics and PolyPeptide have announced a partnership that combines Cytovance’s expertise in microbial and mammalian expression, process development and cGMP manufacturing with PolyPeptide’s capabilities in complex peptide development and manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113598664/en/ Axel Schleyer, CCO of Cytovance Biologics: “Cytovance has been supporting the development and scale-up of microbial and mammalian-expressed biologics for two decades. Combining our strengths with PolyPeptide’s is exactly what our customers and the industry need to support the rapidly advancing market demand.”
Transition Industries and Veolia Partner to Redefine Industrial Water Use at the Pacifico Mexinol Project in Mexico13.1.2025 09:24:00 CET | Press release
Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and hydrogen projects, and Veolia Water Technologies & Solutions, world leader in water technology, have signed an agreement to explore the provision of advanced industrial water technology for the Pacifico Mexinol project in Sinaloa, Mexico. Expected to initiate operations in 2028, Pacifico Mexinol is poised to be the world’s largest standalone ultra-low carbon chemical production facility in the world, with an output of 6,145 metric tons of methanol (MT) per day. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250112655528/en/ The memorandum of understanding (MOU) outlines the collaboration between Transition Industries and Veolia to develop a purpose-driven water strategy for the Pacifico Mexinol project. Designed with Ahome Municipality’s Drinking Water and Sewage Board (JAPAMA), this strategy would make the Pacifico Mexinol site one
Egle Therapeutics Strengthens its Executive Leadership Team With the Appointment of Christophe Quéva, Ph.D., as Chief Executive Officer13.1.2025 09:00:00 CET | Press release
Egle Therapeutics, a clinical-stage biotechnology company advancing the next generation of regulatory T cell (Treg)-focused therapies for oncology and autoimmune diseases, today announced the appointment of experienced biotechnology industry executive, Christophe Quéva, Ph.D., as Chief Executive Officer (CEO). With over 20 years of experience in the biotechnology industry, Dr. Quéva brings a wealth of expertise as Egle transitions into the clinic its two lead drug candidates, EGL-001 and EGL-003. “I am thrilled to join Egle Therapeutics and collaborate with a team renowned for its deep scientific expertise in regulatory T cells and its strong track record in developing innovative drug candidates for immunology and oncology,” said Christophe Quéva, Ph.D. “Egle is uniquely positioned to demonstrate the therapeutic potential of harnessing regulatory T cells for treating both cancer and autoimmune diseases.” “As we transition from a company with preclinical assets to a fully-fledged clinic
Avanzanite Bioscience Announces Appointment of Chief Technical Officer to Accelerate European Expansion and Drive Growth13.1.2025 07:00:00 CET | Press release
Appointment of Jason Cameron as first Chief Technical Officer underscores Avanzanite’s strategic commitment to accelerating revenue growth and expanding its footprint across Europe and beyond. With over 25 years of global pharmaceutical experience, Cameron is poised to enhance Avanzanite’s commercial distribution of orphan medicines and fuel the company’s ambitious growth trajectory. In the short term, Cameron will focus on deepening Avanzanite’s presence in 26 European countries and spearheading the execution of strategic partnerships slated for 2025. Avanzanite Bioscience B.V., a leading commercial-stage specialty pharmaceutical company committed to bringing ground-breaking medicines for rare diseases to market, announced today the appointment of Jason Cameron as Chief Technical Officer (CTO). This move marks a significant step in Avanzanite’s mission to accelerate growth, expand its presence in Europe, and advance the company’s next phase of international partnerships and product la
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom